CI-1002
UNII 7U374ZW3YB

Substance Identification & Data

This profile provides standardized clinical and technical data for Ci-1002, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7U374ZW3YB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 149028-28-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7U374ZW3YB
CAS Registry Number
149028-28-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CI-1002
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C13H14Cl2N2
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
WTPSHLVHJOJDIF-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c12c(N=C3N(C1)CCCCC3)cc(cc2Cl)Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ci-1002. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

CI-1002

Systematic Nomenclature

1,3-DICHLORO-6,7,8,9,10,12-HEXAHYDROAZEPINO(2,1-B)QUINAZOLINE

Technical Codes

PD-142676